Aired: 10:00am ET | 4 June, 2020
In gene and cell therapy, manufacturing capacity, production yields, and supply chain logistics continue to be an area of focus. The increased need for robust process control strategies requires a broad and versatile toolset. With yields as low as 20% for viral vector production, drug developers have to overcome the obstacles of poor process performance. Raw materials must undergo stringent qualification and process characterization is critical to optimize the product yield; this is accomplished with process parameters that can establish control through a workflow.
Osmolality is a measure of solute concentration and an indication of the solution’s osmotic pressure (USP, EP). It provides the concentration of any solution and has several potential applications within cell and gene therapy development and manufacturing.
Attendees will Learn the Following During this Presentation: